Critical for meeting protein targets when appetite is suppressed
Igarashi Y, Nawaz A, Kado T, Bilal M, Kuwano T, Yamamoto S, et al
Clinical trials show average weight loss of 24.2% of body weight at standard doses over 48 weeks
BPC 157 therapys effects are safe concerning the cure of each organ involved, including the brain, heart, lung, liver, kidney, and gastrointestinal tract, and it does not produce any adverse effect on account of its beneficial effects [129,130,131,132,133,134,135,136,137,138,139,140,141,142,168], along with other findings, i.e., so far no reported adverse effects in basic research, LD1 not achieved, no adverse effects in clinical trials [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40]
( 21 ) reported no significant changes in the postprandial secretion of GLP-1 by chlorogenic acid in either NCI-H716 cells or rats
Ethical approval This study has been ethically approved, IR.TBZMED.VCR.REC.1403.076